Stockreport

Ibex Medical Analytics Announces Expansion of its Biopharma Business, Extending AI Pathology Platform into Early Biomarker Development [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Building on its successful collaborations in late-stage biomarker development , Ibex is now extending its platform into earlier translational research, biomarker develop [Read more]